Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on: January 04,2024

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on:January 04,2024

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Updated on: January 30,2024

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Updated on:January 30,2024

Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainIn a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the or

Updated on: January 30,2024

Researchers identify lethal molecular alterations after current therapies fail patients with metastatic melanoma

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainIn a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the or

Updated on:January 30,2024

Radiation oncology workforce expected to remain stable through 2030

by American Society for Radiation OncologyRadiation oncology total residency slot quotas 2010 - 2022. Credit:International Journal of Radiation Oncology*Biology*Physics(2023). DOI: 10

Updated on: January 30,2024

Radiation oncology workforce expected to remain stable through 2030

by American Society for Radiation OncologyRadiation oncology total residency slot quotas 2010 - 2022. Credit:International Journal of Radiation Oncology*Biology*Physics(2023). DOI: 10

Updated on:January 30,2024

Prostate cancer testing in Sweden—a study on cost and effectiveness

byKarolinska InstitutetShuang Hao, PhD student at the Department of Medical Epidemiology and Biostatistics. Credit: Stefan ZimmermanProstate cancer constitutes an essential public health issue,

Updated on: January 03,2024

Prostate cancer testing in Sweden—a study on cost and effectiveness

byKarolinska InstitutetShuang Hao, PhD student at the Department of Medical Epidemiology and Biostatistics. Credit: Stefan ZimmermanProstate cancer constitutes an essential public health issue,

Updated on:January 03,2024

A machine learning tool can help with diagnosing, monitoring colorectal cancer

Updated on: June 18,2025

A machine learning tool can help with diagnosing, monitoring colorectal cancer

Updated on:June 18,2025

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di

Updated on: January 26,2024

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di

Updated on:January 26,2024

CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e

Updated on: April 12,2024

CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e

Updated on:April 12,2024

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on: April 06,2024

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on:April 06,2024

Researchers discover potential new melanoma treatment, giving hope to patients

by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t

Updated on: January 30,2024

Researchers discover potential new melanoma treatment, giving hope to patients

by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t

Updated on:January 30,2024

Scientists unravel mystery of drug response in small cell lung cancer

by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we

Updated on: March 20,2024

Scientists unravel mystery of drug response in small cell lung cancer

by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we

Updated on:March 20,2024

Researchers find a new promising therapeutic target for glioblastoma

by Spanish National Research CouncilGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Glioblastoma is the most frequent and aggre

Updated on: June 19,2024

Researchers find a new promising therapeutic target for glioblastoma

by Spanish National Research CouncilGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Glioblastoma is the most frequent and aggre

Updated on:June 19,2024